Leukemia Research
Volume 23, Issue 8 , Pages 751-762 , August 1999

Prolactin blocks glucocorticoid induced cell death by inhibiting the disruption of the mitochondrial membrane

  • Edda Weimann

      Affiliations

    • INSERM Unite 344, Endocrinologie Moleculaire, 156, rue de Vaugirard, F-75015 Paris, France
    • Corresponding Author InformationCorresponding author. Present address: Medical Center for Child Health, Clinic for Paediatric Endocrinology and Metabolism, JW Goethe University, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. Tel.: +49-69-6301-6689; Fax: +49-69-6301-7159
    • ,
  • Elena Baixeras

      Affiliations

    • INSERM Unite 344, Endocrinologie Moleculaire, 156, rue de Vaugirard, F-75015 Paris, France
    • ,
  • Naoufal Zamzami

      Affiliations

    • CNRS UPR 420,19 rue Guy Moquet, BP 8, F-94801 Villejuif, France
    • ,
  • Paul Kelly

      Affiliations

    • INSERM Unite 344, Endocrinologie Moleculaire, 156, rue de Vaugirard, F-75015 Paris, France

Received 17 August 1998 ,Accepted 7 October 1998.

References 

  1. Fletcher-Chiappini SE, Compton MM, LaVoie HA, Day EB, Witorsch RJ. Glucocorticoid prolactin interactions in Nb2 lymphoma cells: antipoliferative vs. anticytolytic effects. Proc. Soc. Exp. Biol. Med. 1993;202:345–352
  2. Caron-Leslie L, Cidlowski J. Similar action of glucocorticoids and calcium on the regulation of apoptosis in S49 cells. Mol. Endocrinol. 1991;5:1169–1179
  3. Pratt WB, Sanchez ER, Bresnick EH, Meshinchi S, Scherrer LC, Dalman FC, et al.  Interaction of the glucocorticoid receptor with Mr 90,000 heat shock protein: An involving model of ligand mediated receptor transformation and translocation (supplement). Cancer. Res. 1989;49:2222s–2229s
  4. lshizaki Y, Cheng L, Mudge AW, Raif MC. Programmed cell death by default in embryonic cells, fibroblasts and cancer cells. Mol. Biol. Cell. 1995;6:1443–1458
  5. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO. J. 1995;14:452–460
  6. Angel P, Karin M. The role of Jun, Fos, AF-1 complex in ceIl-proliferation and transformation. Biochim. Biophys. Acta. 1991;1072:129–157
  7. Zhou F, Thompson EB. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Mol. Endocrinol. 1996;10:306–316
  8. Thulasi R, Harbour DV, Thompson EB. Suppression of c-myc is a critical step in glucocoricoid induced human leukemic cell lysis. J. Biol. Chem. 1993;268:18306–18312
  9. lwata M, lseki R, Sato K, Tozawa Y, Ohoka Y. Involvement of protein kinase C in glucocorticoid induced apoptosis in thymocytes. Int. Immunol. 1994;6:431–438
  10. Zamzami N, Marchetti P, Castedo M, Decaudin D, Maho A, Hirsch T, et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995;182:367–377
  11. Geley S, Hanmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, et al.  The interleukin 1β-converting enzyme inhibitor CrmA prevents Apo1/Fas-but not glucocorticoid-induced poly (ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett. 1997;402:36–40
  12. Li M, Liu X, Robinson G, Bar-Peled U, Wagner KU, Young WS, et al.  Mammary derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA. 1997;94:3425–3430
  13. Travers MT, Barber MC, Tonner E, Quanle L, Wilde CJ, Flint DJ. The role of prolactin and growth hormone in the regulation of casein gene expression and mammary cell survival: relationship to milk synthesis and secretion. Endocrinology. 1996;137:1530–1539
  14. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley A. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology. 1996;137:5456–5462
  15. Reed JC. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 1995;124:1–6
  16. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Ann. Rev. Immunol. 1995;13:513–543
  17. Susin SA, Zamzami N, Castedo M, Hirsch Z, Marchetti F, Macho A, et al.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 1996;184:1331–1341
  18. Nicoletti IG, Migliorati MC, Pagliacci , Ricardi C. A rapid simple method for measuring thymocyte apoptosis by propidium iodine staining and flow cytometry. J. Immunol. Methods. 1991;139:271
  19. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al.  Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 1996;184:1155–1160
  20. Zamzami N, Marchetti P, Castedo M, Zanin C, Vaysiiere JL, Petit PX, et al.  Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 1995;181:1661–1672
  21. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol. Today. 1997;18:44–51
  22. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cellfree extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–157
  23. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, et al.  Mitochondrial control of nuclear apoptosis. J. Exp. Med. 1996;183:1533–1544
  24. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, et al.  The central executioner of apoptosis. Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide apoptosis. J. Exp. Med. 1997;186:1–13
  25. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti F, Macho A, et al.  Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 1996;157:512–521
  26. Oltavi ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell. 1993;74:609–619
  27. Clevenger CV, Thickman K, Ngo W, Chang WP, Takayama S, Reed JC. Role of bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, BA/F3 and Nb2. Mol. Endocrinol. 1997;11:608–618
  28. Jacobson MD, Weil M, Raif MC. Role of Ced-3/ICE-family proteases in staurosporine induced programmed cell death. J. Cell. Biol. 1996;133:1041–1051
  29. Robenson NM, ZangrilIl J, Fernandes-Alnemri T, Friesen FD, Litwak G, Alnemri ES. Baculovirus p35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res. 1997;57:43–47
  30. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly (ADP-ribose) polymerase by proteinase with properties like ICE. Nature. 1995;371:346–347
  31. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousands cuts?. Cell. 1995;82:349–352
  32. Estoppey S, Rodriguez I, Sadoul R, Martinou JC. Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis. Cell Death Diff. 1997;4:34–38
  33. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A. Evidence for CPP32 activation in the absence of apoptosis during T-lymphocyte stimulation. J. Biol. Chem. 1997;272:13459–13462

PII: S0145-2126(99)00050-8

Leukemia Research
Volume 23, Issue 8 , Pages 751-762 , August 1999

Article Tools

* Image Usage & Resolution